risankizumab
abbvie
[' psa']
long term rzb provides durable efficacy response in psa through 100 weeks. no new safety signals. abs 2145 #acr22 
Passionately curious rheumatologist, world traveler, wife, mother, sister, daughter, friend, dog lover. Believer in scientific method & evidence based medicine.